naringenin has been researched along with sb 203580 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhutani, KK; Garg, D; Kadam, RU; Paul, AT; Roy, N | 1 |
Li, X; Liu, F; Luo, J; Yang, H; Yang, Y; Zhao, Q | 1 |
2 other study(ies) available for naringenin and sb 203580
Article | Year |
---|---|
Evaluation of proinflammatory cytokine pathway inhibitors for p38 MAPK inhibitory potential.
Topics: Anti-Inflammatory Agents; Biflavonoids; Cytokines; Flavanones; Flavones; Flavonoids; Glucosides; Hydrogen Bonding; Imidazoles; Luteolin; Models, Molecular; p38 Mitogen-Activated Protein Kinases; Pyridines; Structure-Activity Relationship | 2007 |
Naringenin Exerts Cardiovascular Protective Effect in a Palmitate-Induced Human Umbilical Vein Endothelial Cell Injury Model via Autophagy Flux Improvement.
Topics: Acetylcysteine; Anthracenes; Apoptosis; Autophagy; Cardiotonic Agents; Chloroquine; Endothelium, Vascular; Flavanones; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; MAP Kinase Signaling System; Nitric Oxide; p38 Mitogen-Activated Protein Kinases; Palmitates; Pyridines; Reactive Oxygen Species | 2019 |